Lisa M. Broad is a physiologist and pharmacologist with over 25 years of research experience in academia and industry. They have extensive knowledge in drug discovery and development, focusing on the Neuroscience therapeutic area and developing treatments for chronic pain, migraine, and neurodegenerative diseases. Currently, Lisa serves as Vice President and Head of Neurodegeneration Discovery Research at Eli Lilly and Company, as well as Managing Director of Lilly Research Labs in the UK. Previously, Lisa completed post-doctoral studies at both the National Institute of Environmental Health Sciences and the University of Cambridge, where they also earned a PhD in Pharmacology.
This person is not in any teams
This person is not in any offices